Patents Assigned to Wallkill BioPharma, Inc.
  • METHODS FOR REDUCING ELEVATED GLUCOSE LEVELS
    Publication number: 20200405772
    Abstract: Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.
    Type: Application
    Filed: September 28, 2018
    Publication date: December 31, 2020
    Applicant: Wallkill BioPharma, Inc.
    Inventors: Gerald F. SWISS, David KIEWLICH
  • Treating diabetes with genetically modified beta cells
    Patent number: 10696950
    Abstract: Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: June 30, 2020
    Assignee: Wallkill BioPharma, Inc.
    Inventors: Gerald F. Swiss, David Kiewlich
  • TREATING DIABETES WITH GENETICALLY MODIFIED BETA CELLS
    Publication number: 20190100729
    Abstract: Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 4, 2019
    Applicant: Wallkill BioPharma, Inc.
    Inventors: David Kiewlich, Gerald F. Swiss
  • TREATING DIABETES WITH GENETICALLY MODIFIED BETA CELLS
    Publication number: 20190100730
    Abstract: Described herein are human transgenic beta cells expressing fugetactic levels of CXCL12 to a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL12.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 4, 2019
    Applicant: Wallkill BioPharma, Inc.
    Inventors: Gerald F. Swiss, David Kiewlich